AAVVF Advantage Oil & Gas Ltd.
- 8.044
- +0.104+1.31%
Advantage Oil & Gas Ltd. News
Advantage Announces Annual General and Special Meeting Voting Results on Election of Directors
Earnings Call Summary | Advantage Oil & Gas Ltd.(AAVVF.US) Q1 2024 Earnings Conference
The following is a summary of the Advantage Energy Ltd. (AAVVF) Q1 2024 Earnings Call Transcript:Financial Performance:Advantage Energy reported Q1 2024 adjusted funds flow of $67 million with capital
Advantage Announces First Quarter 2024 Conference Call
Advantage Announces Changes to Its Board of Directors
Earnings Call Summary | Advantage Oil & Gas Ltd.(AAVVF.US) Q4 2023 Earnings Conference
The following is a summary of the Advantage Energy Ltd. (AAVVF) Q4 2023 Earnings Call Transcript:Financial Performance:Advantage Energy reported an exceptional performance with record production and s
CIBC Maintains Neutral on Advantage Energy, Raises Price Target to $10.5
CIBC analyst Jamie Kubik maintains Advantage Energy (OTC:AAVVF) with a Neutral and raises the price target from $9.75 to $10.5.
Advantage Energy Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 33.79% CIBC $9.75 → $10.5 Maintains Neutral
Advantage Energy GAAP EPS of C$0.25, Revenue of C$147.14M
Advantage Announces 2023 Year-End Conference Call
Advantage Announces Operational Update Including Record Production and Reduced Capital Spending Outlook
Will Weakness in Advantage Energy Ltd.'s (TSE:AAV) Stock Prove Temporary Given Strong Fundamentals?
Canada Growth Fund to Invest $200M in Alberta Carbon Capture Firm
Advantage Oil & Gas Beats Q3 Top and Bottom Line Estimates; Reaffirms FY23 Outlook
Advantage Energy GAAP EPS of C$0.02, Revenue of C$107.24M
BMO Capital Boosts Advantage Energy Price Target By 17%
Advantage Energy Ltd (TSX:AAV) (OTC:AAVVF) price target has been raised to C$14 from C$12 by BMO Capital analyst Mike Murphy.The analyst maintained the Outperform rating on the shares.The analyst stat
Advantage Oil & Gas GAAP EPS of C$0.10, revenue of C$177.57M
Advantage Oil & Gas press release (OTCPK:AAVVF): Q1 GAAP EPS of C$0.10.Revenue of C$177.57M (+78.7% Y/Y).Record cash provided by operating activities of C$109.2 millionRecord adjusted funds flow
Advantage Oil & Gas GAAP EPS of C$1.90, revenue of C$159.26M
Advantage Oil & Gas press release (OTCPK:AAVVF): Q4 GAAP EPS of C$1.90; AFFO of C$0.37. Revenue of C$159.26M (+117.6% Y/Y). Record annual production of 49,445 boe/d (269.7 mmcf/d natural gas, 4,49
Advantage Oil & Gas reports Q3 results
Advantage Oil & Gas (OTCPK:AAVVF): Q3 GAAP EPS of C$0.23; AFFO of C$0.33.Revenue of C$110.34M (+97.9% Y/Y)Press ReleaseRecord total production of 50,025 boe/d (271.8 mmcf/d natural gas, 4,724 bbls
Musk: supply chain problems persist. Delivery of the new Roadster has been delayed until 2023.
Tesla, Inc. CEO Elon Musk said on Wednesday that the delivery of the new electric sports car Roadster was postponed to 2023 at the earliest as supply chain shortages continued to put pressure on the company. Musk wrote on social media: "2021 is a year of severe shortage in the supply chain, so it is useless for us to have 17 new products because none of them will be delivered. Assuming there is no major drama in 2022, the new Roadster should be shipped in 2023. " Tesla, Inc. is not the only carmaker dealing with supply chain pressures. Others, including Toyota and Ford
Pfizer Inc submitted early data on vaccine enhancement to FDA.
Early data submitted by Pfizer Inc and BioNTech SE to US regulators showed that a third dose of their Covid-19 vaccine eight to nine months after the completion of the initial vaccination program produced higher levels of protective antibodies. According to Monday's announcement, the two companies expect to have the results of a larger final phase of the trial soon, which will be submitted to the U.S. Food and Drug Administration, the European Drug Administration and other regulators. Pfizer Inc said last month that based on early data, the company would apply to US regulators for emergency use authorization for its vaccine. Early data show that vaccination
Analysis
Price Target
No Data
